02:26 PM EDT, 06/26/2025 (MT Newswires) -- Globavend ( GVH ) priced an offering of 21.7 million common shares and pre-funded warrants, targeting total proceeds of $15 million.

The stock slumped 73% as intraday volume topped 53.5 million shares versus the daily average of about 548,000.

Reviva Pharmaceuticals ( RVPH ) priced an offering of 20 million common shares, along with Series C and Series D warrants to purchase up to 20 million shares each, for gross proceeds of $10 million.

The shares fell 52% as volume topped 18.4 million versus the daily average of almost 689,000.

Equinix ( EQIX ) expects annual revenue growth of 7% to 10% through 2029, based on its long-term outlook. BofA Securities, HSBC and TD Cowen lowered their price targets on the stock.

The shares fell 8.2% as volume topped 2.87 million versus the daily average of almost 592,000.

Price: 0.19, Change: -0.51, Percent Change: -73.09